Moreover, clinical data from the TCGA database reveals a significant correlation between high CYP19A1 expression and poor overall survival in chemotherapy-treated CRC patients, further substantiating the clinical relevance of our findings. Here, CYP19A1 is linked to colorectal carcinoma.